Goldman Sachs Group Inc Rallybio Corp Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.34 - $2.98 $225,065 - $500,517	167,959 Added 1268.29%	181,202 $242,000
Q1 2024 May 15, 2024	SELL	$1.25 - $2.4 $7,218 - $13,860	-5,775 Reduced 30.37%	13,243 $24,000
Q4 2023 Feb 13, 2024	BUY	$1.91 - $4.39 $8,640 - $19,860	4,524 Added 31.21%	19,018 $45,000
Q3 2023 May 14, 2024	SELL	$3.37 - $6.16 $15,245 - $27,867	-4,524 Reduced 23.79%	14,494 $48,000
Q3 2023 Nov 14, 2023	SELL	$3.37 - $6.16 $106,357 - $194,409	-31,560 Reduced 68.53%	14,494 $48,000
Q2 2023 May 14, 2024	BUY	$4.31 - $8.89 $109,797 - $226,472	25,475 Added 123.79%	46,054 $260,000
Q2 2023 Aug 14, 2023	BUY	$4.31 - $8.89 $109,797 - $226,472	25,475 Added 123.79%	46,054 $260,000
Q1 2023 May 14, 2024	SELL	$4.37 - $8.75 $1,179 - $2,362	-270 Reduced 1.3%	20,579 $117,000
Q1 2023 May 11, 2023	SELL	$4.37 - $8.75 $1,179 - $2,362	-270 Reduced 1.3%	20,579 $117,000
Q4 2022 May 14, 2024	SELL	$4.67 - $14.86 $59,159 - $188,246	-12,668 Reduced 37.8%	20,849 $136,000
Q4 2022 Feb 13, 2023	SELL	$4.67 - $14.86 $59,159 - $188,246	-12,668 Reduced 37.8%	20,849 $136,000
Q3 2022 May 14, 2024	SELL	$7.54 - $14.56 $32,580 - $62,913	-4,321 Reduced 11.42%	33,517 $485,000
Q3 2022 Nov 10, 2022	SELL	$7.54 - $14.56 $32,580 - $62,913	-4,321 Reduced 11.42%	33,517 $484,000
Q2 2022 May 14, 2024	BUY	$6.26 - $13.65 $117,813 - $256,893	18,820 Added 98.96%	37,838 $285,000
Q2 2022 Aug 15, 2022	BUY	$6.26 - $13.65 $141,156 - $307,793	22,549 Added 147.49%	37,838 $285,000
Q1 2022 May 16, 2022	BUY	$6.91 - $15.04 $15,367 - $33,448	2,224 Added 17.02%	15,289 $107,000
Q4 2021 Feb 14, 2022	BUY	$9.3 - $19.91 $121,504 - $260,124	13,065 New	13,065 $125,000

Others Institutions Holding RLYB

# of Institutions

Shares Held

31.9M

Call Options Held

Put Options Held

Viking Global Investors LP

4.19M
Shares

$3.99 Million
0.02% of portfolio
Johnson & Johnson New Brunswick, NJ

3.64M
Shares

$3.45 Million
1.36% of portfolio
5 Am Venture Management, LLC San Francisco, CA

3.63M
Shares

$3.45 Million
1.69% of portfolio
New Leaf Venture Partners, L.L.C. New York, NY

3.3M
Shares

$3.14 Million
3.98% of portfolio
Tpg Gp A, LLC Fort Worth, TX

3.03M
Shares

$2.88 Million
0.08% of portfolio

View Full List

About Rallybio Corp

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $30.5M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

More about RLYB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account